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ABSTRACT 
HITOMI AKIMOTO: Biological Modification of Titanium Surfaces 
Using Bifunctional Peptides 
(Under the direction of Lyndon F Cooper, DDS, PhD) 
The clinical success of endosseous implants is associated with the formation and 
maintenance of bone at implant surfaces. Based on in vivo observations, several 
generalizations have been derived regarding the nature of the interface. Most 
prominently, initial cell and molecular adhesion dictate the reactivity of the interface.   
The aim of this project is to use interfacial biomaterials (Ti-binding peptides) to graft cell 
adhesive peptides to titanium surfaces used for osseointegrated endosseous implants. We 
hypothesized that there is statistical significant difference in the differentiation of cells 
adherent with Ti-binding peptide treated and untreated on titanium surfaces. We used the 
peptide (AFF6008) can facilitate the adhesion of biologically active peptides to the 
titanium surface. Scanning electron microscopy was used to quantify cell adhesion on 
treated and untreated surfaces. Real time polymerase chain reaction was used to measure 
and compare osteoblast-specific gene expression, ALP and BSP, associated with 
osteoblastic differentiation in cells cultured on treated and untreated surfaces. 
 
 iii
DEDICATION 
 
 
To my grand parents,  
Kiyoshi and Shima Sakamoto,  
who always believed in me and gave me support throughout my whole life. 
To my husband and Pochi;  
who have been inspiring and encouraging with unreserved understanding throughout the  
 
course of my residency years. 
 iv
ACKNOWLEDGMENTS 
 
My sincere thanks to my mentor, Dr. Lyndon Cooper, for his valuable support and 
scientific guidance throughout the investigation. 
I wish to extend my warmest thanks to all my graduate prosthodontic faculties, 
residents. Specially, I would like to thank Dr. Juanli Guo, Ms. Beth Stirling, Ms. Sara 
Valencia, Ms. Jin Yi Kwon, and Mr. Wallace Ambrose for the scientific guidance. 
This work was financially supported by research grant from the American College 
of Prosthodontists/ESPE Fellowship in Geriatric Prosthodontics. 
 
 
 v
TABLE OF CONTENTS 
 
     Page 
LIST OF FIGURES ............................................................................................................... vii 
LIST OF ABBREVIATION AND SYMBOLS ...................................................................viii 
CHAPTER 1.     INTRODUCTION ...................................................................................... 1 
CHAPTER 2.     MATERIAL AND METHODS ............................................................ ….5 
CHAPTER 3.     RESULTS .................................................................................................... 9 
CHAPTER 4.     DISCUSSION ............................................................................................ 23 
CHAPTER 5.     CONCLUSIONS ....................................................................................... 34 
REFERENCES..................................................................................................................... 35 
 
 
 
 
 
 
 vi
LIST OF FIGURES 
 
FIGURE                                                                                                                         Page 
1. IFBM treatment on titanium adherent osteoblastic differentiation.................................. 12 
2 -a.  SEM of the osteoblastic cell culture with Ti-binding RGD 30 min ............................. 13 
2-b.  SEM of the osteoblastic cell culture with Ti-binding RGD 60 min .............................. 14 
2-c.  SEM of the osteoblastic cell culture with Ti-binding RGD 120 min ............................ 15 
2-d.  SEM of the osteoblastic cell culture with Ti-binding RGD 240 min ............................ 16 
3-a.  SEM of the osteoblastic cell culture with Polystryene binding RGD 30 min ............... 17 
3-b.  SEM of the osteoblastic cell culture with Polystryene binding RGD 60 min ............... 18 
3-c.  SEM of the osteoblastic cell culture with Polystryene binding RGD 120 min ............. 19 
3-d.  SEM of the osteoblastic cell culture with Polystryene binding RGD 240 min ............. 20 
3-e.  SEM of the osteoblastic cell culture with Ti-binding RGD 240 min ............................ 21 
4. The expression levels of BSP mRNA.............................................................................. 22 
5. The expression levels of Alkaline phosphatase mRNA................................................... 23 
 
 vii
LIST OF ABBREVIATIONS 
ALP:     Alkaline phosphatase 
BMP:         Bone morphogenetic protein 
BSP:         Bone sialoprotein 
cpTi:                    Comercially pure titanium 
DMEM:  Dulbecco’s Modified Eagle’s Medium 
cDNA:         Complementary Deoxyribonucleic acid 
EDTA:        Ethylenediamine tetra-acetic acid 
GAPDH:        Glyceraldehydes 3-phosphate dehydrogenase 
GRGDS:              Glycine-arginine-glycine-aspartate-serine 
GRGES:              Glycine-arginine-glycine-glutamic acid-serine 
hMCS:                 Human mesenchymal cells 
HCl:         Hydrogen chloride 
IFBM:                 Interfacial biomaterial 
IgE:              Immunoglobulin E 
LPS:         Lipopolysacharide 
mRNA:  Messenger Ribonucleic acid 
NaOH:         Sodium hydroxide 
OC:                      Osteocalcin 
OPN:                   Osteopontin 
PBS:         Phosphate-buffered saline 
PCR:         Polymerase chain reaction 
PDGF-β:         Platelet derived growth factor beta 
Real-time PCR    Real-time polymerase chain reaction 
RNA:                   Ribonucleic 
SLA:         Sandblasted large-grit acid-etched 
TGF-β:  Transforming growth factor β 
Ti:   Titanium 
TIMP:         Tissue inhibitors of metalloproteinases 
UNC:         University of North Carolina 
 viii
CHAPTER 1 
INTRODUCTION 
 
In this decade, endosseous dental implants have facilitated dramatically in dentoalveolar 
replacement.  The use of endosseous implants to retain craniofacial prostheses (ears, noses, 
etc.) is also successful and may have even greater impact on the well being of the 
individual(Kosmidou, Toljanic et al. 1998; Abrahamsson, Zitzmann et al. 2001; 
Abrahamsson, Zitzmann et al. 2002; Abrahamsson, Berglundh et al. 2004; Albrektsson and 
Wennerberg 2004; Albrektsson and Wennerberg 2004) Implants are most recently implicated 
in craniofacial regeneration; distraction osteogenesis is a process that is being applied in the 
most challenging of regenerative situations.(McCarthy, Williams et al. 1998) Unfortunately, 
dental implant use requires sufficient quantity and quality of bone.  A major impediment to 
endosseous implant use is the absence of bone that occurs most commonly in traumatic 
injuries to the craniofacial region and in aplasias and dysphasia’s affecting the teeth, alveolar 
ridges and jaws of individuals affected with congenital or acquired defects.  For these most 
challenging situations, further improvements in dental implant success is dependent on the 
clinical ability to create or replace bone at the implant surface.(Esposito, Hirsch et al. 1998) 
Dental implant success is high where sufficient bone supports osseointegration.  
However, in locations of low bone density and volume, implant success is 
diminished.(Esposito, Hirsch et al. 1998)   Implant placement in regenerated bone is required 
several surgical procedures.  Imparting osteoinductive or osteoconductive behavior to 
implants could improve bone formation at implants.  Hydroxyapatite coating of titanium 
implants promotes osteoconduction.(Esposito, Hirsch et al. 1998)  However, hydroxyapatite 
implant surfaces are also associated with peri – implant inflammation, bone loss(Iamoni, 
Rasperini et al. 1999) and increased failure rates after 5 – 7 years.(Salcetti, Moriarty et al. 
1997)  Titanium offers many biologic and mechanical advantages for creating tooth root 
analogs and serving a role in the surgical reconstruction of the craniofacial complex.  Other 
methods of increasing bone formation at titanium surfaces are required. 
Buser et al. demonstrated that increasing surface roughness beyond the machined 
titanium surface could increase (approaching that of hydroxyapatite) the amount of bone 
formed at the implant surface.(Buser, Nydegger et al. 1999) Gotfredsson also showed the 
benefit of rough titanium surfaces for bone formation early in healing of implants.(Block, 
Gardiner et al. 1996)  In a series of reports, surface roughness parameters associated with 
reproducible increases in the extent of bone formed at the implant, will be 
identified.(Gotfredsen, Wennerberg et al. 1995)   However, a biological theory or a 
biomechanical theory for this behavior remains undefined.  A biomechanical theory of 
formed bone behavior at rough implant surfaces fails to identify the bone formation effects 
previously observed at rough implants.  One possible explanation is greater cell adhesion on 
rough implant surfaces, however, cell culture studies do not fully support this.  Other 
modifications to increase cell adhesion may be considered. 
Many clues for tissue engineering success can be obtained by studying osseointegration, 
the process of bone formation and maintenance around an endosseous implant in function. 
Osseointegration as tissue engineering represents the planned cell activity within a given 
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matrix and cytokine environment.  We strive to develop devices that are biocompatible, form 
tissues physiologically, and biomechanically equivalent to the missing structure.   Further 
engineering of the cell, the matrix or the cytokines comprising a tissue forming device 
demands a complete understanding of the device’s clinical or modeled clinical environments, 
including the phenotypic spectrum of the adherent cell population.(Hubbell 1995) 
Based on investigations at the molecular level, implant substrate - osteoblast interactions 
may be characterized as specific, protein - mediated (indirect), dynamic and signal-
generating events.  Osteoblasts utilize integrin receptors to bind specific proteins absorbed on 
implant surfaces.(Kim and Mooney 1998)   Some of these proteins present in serum are 
extracellular matrix proteins, or are expressed by osteoblasts. Examples include cell adhesion 
proteins such as collagen, fibronectin or osteopontin. This process is specific in two ways; 
first, adhesive proteins mediating attachment may be specific for bone or a particular implant 
surface and second, the osteoblast display of integrins is differentiation and matrix protein - 
specific.(Puleo and Bizios 1992)   Compelling evidence for this is provided by the 
observation that cultured osteoblasts utilize different receptors for attachment to polystyrene, 
titanium and cobalt chrome alloy substrates.(Schneider and Burridge 1994) 
Integrin receptors are heterodimeric transmembrane receptors that bind specifically to 
extracellular matrix proteins.  Many of the integrins bind to a common peptide motif, Arg-
Gly- Asp (RGD).  Numerous investigators have attempted to use the RGD motif to activate 
different biomaterials using the RGD encoding peptides.  While this has been attempted for 
metal surfaces, complex chemistries are often involved in covalently bonding the RGD 
peptide to the metal surface.  More recent studies have demonstrated that placement of RGD 
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containing peptides onto titanium implants is possible but difficulties in complex chemistries 
remain.(Sinha and Tuan 1996) 
General structureal and biological properties of noncollagenous proteins associated with 
the bons cell extracellular matrix.(Heinegard and Oldberg 1989) 
The aim of this project is to use peptide affinity for titanium itself to simplify this strategy 
and permit the direct adhesion of peptides containing RGD to promote cell adhesion.  
Scanning Electron Micrographic analysis of cell adhesion to AFF6008 (bifunctional 
peptide) treated titanium surfaces 2 and 8 hours following plating of human mesenchymal 
stem cells showed cell morphology. Early studies were performed using grit blast/etched 
surfaces.  This image indicates the ability to identify spread and round cells adherent to the 
surface after early time points (2 hr) and the effectiveness of the surface treatment in 
directing cell adhesion as well as spreading (8 hr). Manual counting of cells (0 – 4 hours) 
enables definition of bifunctional peptide surface treatment effects on cell attachment and 
spreading.  Quantification of human mesenchymal stem cell adhesion on titanium disks 
treated for 2 hours with 0 – 5 μM AFF 6005 was prepared. Triangle cells were associated 
with (non soluble RGD); Circler (soluble RGD).  The results suggest that the peptide adheres 
to the titanium and directs RGD-dependent binding of osteoblastic cells. 
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CHAPTER 2 
MATERIAL AND METHODS 
 
Titanium surface preparation 
 
A preparation method described by Keller et al was used to provide a clean, passive 
Ti alloy surface for cell culture. Bulk Ti disks were prepared from cp Titanium.  The 5mm 
diameter by 1.5mm thick sections were cut and polished by 600 grits with silicon carbide 
abrasive paper. These sections were washed, ultrasonically cleaned in ethyl methyl ketone. 
Then, they were rinsed five times in deionizer distilled water, and acid passivity in 40% nitric 
acid. Proper to use, these surfaces were sterilized by immersion in absolute ethanol. 
Phage display emerged as a technology for the identification of peptides that bind to 
protein targets.  It has evolved as a technology for the identification of peptides that bind to 
polymers, metals, and other materials.(Okamoto, Matsuura et al. 1998) 
 
Preparation of peptides 
 
The peptide AFF6008 was provided from Affinergy Inc. This peptide contains a 
proprietary titanium binding domain, a linker region and the RGD motif. Using the AFF6008 
peptide a stock solution of 1mM was made in sterile phosphate buffered saline (PBS), and 
diluted in PBS to 10μM (100x), 1 μM (1000x), 0.1 μM (10,000x). 
Assessments of IFBM-mediated cell adhesion 
 
Scanning Electron Micrographic analysis of cell adhesion to AFF6008 treated titanium 2 and 
8 hours following plating of human mesenchymal stem cells : Early studies were performed using grit 
blast/etched surfaces.  This image indicates the ability to identify spread and round cells adherent to 
the surface after early time points (2 hr) and the effectiveness of the surface treatment in directing cell 
adhesion as well as spreading (8 hr). Manual counting of cells (0 – 4 hours) enables definition of 
bifunctional peptide surface treatment effects on cell attachment and spreading.  Quantification of 
human mesenchymal stem cell adhesion on titanium disks treated for 2 hours with 0 – 5 μM AFF 
6005 was prepared. 
Human MSCs were plated onto 5 mm disks in 100 μl of DMEM containing 10% FBS 
at a concentration of 5 x 105 cells/ml and incubated in a humidified 5% CO2 atmosphere at 
37° C for 0~4 hours.  Adherent cells and disks were rinsed three times with ice cold PBS and 
fixed for 60 minutes with 2.5 % glutaraldehyde, 2 % paraformaldehyde, and 0.1 M sodium-
cacodylated buffer (pH 7.4) and post-fixed in 4% osmium tetroxide.  The fixed cell layers 
were washed with PBS and dehydrated using graded ethanol solutions and critical point 
drying.  Human MSC adhesion and morphology (spread versus round) were examined using 
SEM (Joel 6300 microscope; Joel USA, Inc., Peabody MA).  Cell adhesion were determined 
by averaging the number of cells counted at low magnification (× 500) in three random areas 
per disk, and calculation of the mean counts from five disks for each of the different prepared 
surfaces. A single examiner using the presence of cell processes and the elongation of the 
central cytoplasm region as criteria for a spread cell shall manually score cell morphology.  
The numbers of spread and round cells were counted in three random areas per disk.  Mean 
numbers were calculated for five disks for each of the different prepared surfaces. 
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Competition experiments using soluble GRGDS and GRGES peptides (Sigma, St. Louis 
MO) were used to demonstrate the specificity of cellular interactions. 
 
Assessment of IFBM treatment on titanium adherent osteoblastic differentiation 
 
Human MSCs were plated on titanium disks treated with IFBM  (interfacial 
biomaterial) (AFF6008) or with PBS according to concentration (10μM) and time (4 hours). 
This results in optimal cell adhesion and spreading indicated in studies performed in 
assessments of IFBM-mediated cell adhesion.  Twenty four hours following plating under 
such conditions, cells were examined for osteoblastic differentiation over a 14 day culture 
period. 
Briefly, human MSCs (Clonetics, Inc) was treated with growth media containing 
osteogenic supplements (OS; 0.1μM dexamethasone, 0.05mM ascorbic acid and 10mM β-
glycerophosphate). Cells were cultured for 1-14 days, replacing OS medium every 
other.(Matsuzaka, Walboomers et al. 1999)  Osteoblastic differentiation was examined at 3, 
7, and14 days as a function of one or another inflammatory agent.  Results were quantified 
by scanning, and reported as mean ± SEM, n = 4 wells/group and compared by ANOVA, P < 
0.05. 
Real Time- PCR analysis were used to measure Alkaline phosphatase and BSP 
mRNA expression.(Harris and Cooper 2004) Reverse transcription reactions for all RNA 
samples were performed using 2 μg of total RNA to program standard Superscript™ 
reactions.  Each 1st strand cDNA synthesis reaction generates sufficient cDNA to perform > 
20 reactions. To account for potential variations among the 1st strand cDNA synthesis 
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reactions, synthesized cDNA were examined by GAPDH control reactions.  Real time PCR 
reactions were performed using an ABI Thermocycler as described.(Diefenderfer, Osyczka et 
al. 2003)  The relative abundance of bone specific mRNAs were used to demonstrate the 
effects of treatments on hMSC osteoblast differentiation.  The fold induction of each mRNA 
at 3, 7 and 14 days is used to describe osteoblastic differentiation. 
 
Statistical Analyses 
 
All experiments were performed using 5 disks per time point and every experiment 
was reproduced using hMSC donor.  2 way ANOVA was used to statistically compare results 
between concentration and time. 
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                                                 CHAPTER 3 
RESULT 
 
Specification of cell adhesion to cpTitanium substrates 
 
Human MSC adhesion and morphology (spread versus round) were examined using 
SEM. Cell adhesion was determined by averaging the number of cells counted at low 
magnification (× 500) in three random areas per disk, and mean counts from five disks for 
each of the different prepared surfaces. At 0.1μM the round cell and the spread cell increased 
at 5min, then the numbers decreased until 30min. At the 1.0 μM, the round cells and spread 
cells decreased in number at 5min. However, at 10μM, the round cells decreased and the 
spread cell increased at 5min. With time, the round cells transformed into spread cell 
patterns. In addition, the spread cells became more mature and the size expanded. (Figure 1) 
 
Figure 2 a~d and Figure 3 a~e: 
 
Demonstrate that titanium binding IFBM (interfacial biomaterial) mediates cell adhesion 
in substrate and legend specific manner 
In the early stage of Ti binding RGD and polystyrene RGD, the size of the spread cell 
and round cell were small, similar to the morphology of dendric cells.  They were spread out 
across the surface and grew as a monolayer. However, in the late stage, the dimension of the 
spread cell increased and induced the cells to grow as multiple layers. In addition, the 
round cells grew as a continuous, thin monolayer across the surface of the existing 
monolayer.  
 
The expression levels of BSP and Alkaline phosphatase mRNA determined by Real 
Time PCR is presented in Fig. 4 and 5. The data demonstrated that day 1, day 3, and day 7 of 
BSP expression, at which time the responding cells had not yet differentiated to osteoblasts 
as confirmed by the BSP. However, at day 14, the BSP expression had significantly 
increased. Moreover, when comparing cells with peptide and cells without peptide, the ones 
with peptide had significantly higher BSP expression. (Figure 4) 
 
ALP is an enzyme expressed on the membrane of osteoblastic cells and has been used 
as a marker for osteoblastic activity. In this study, ALP expression was significantly higher 
with RGD peptide than without the peptide at day 7 and day 14, and the achievement of the 
maximum ALP activity was day 7. Both with the RGD peptide and without peptide showed 
very low ALP activity at day 1 and day 3. (Figure 5) 
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Figure 1 
Assessment of IFBM treatment on titanium adherent osteoblastic differentiation 
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Morphology of the titanium surfaces 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2-a 
Scanning electron micrograph of the osteoblastic cell culture with Ti-binding RGD 30 min 
after seeding the culture. Bar = 10μm 
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Figure 2-b 
Scanning electron micrograph of the osteoblastic cell culture with Ti-binding RGD 60 min 
after seeding the culture. Bar = 10μm 
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Figure 2-c 
Scanning electron micrograph of the osteoblastic cell culture with Ti-binding RGD 120 min 
after seeding the culture. Bar = 10μm 
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Figure 2-d 
Scanning electron micrograph of the osteoblastic cell culture with Ti-binding RGD 240 min 
after seeding the culture. Bar = 10μm 
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Figure 3-a 
Scanning electron micrograph of the osteoblastic cell culture with Polystryene binding RGD 
30 min after seeding the culture. Bar = 10μm 
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Figure 3-b 
Scanning electron micrograph of the osteoblastic cell culture with Polystryene binding RGD 
60 min after seeding the culture. Bar = 10μm 
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Figure 3-c 
Scanning electron micrograph of the osteoblastic cell culture with Polystryene binding RGD 
120 min after seeding the culture. Bar = 10μm 
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Figure 3-d 
Scanning electron micrograph of the osteoblastic cell culture with Polystryene binding RGD 
240 min after seeding the culture. Bar = 10μm 
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Figure 3-e 
 
Scanning electron micrograph of the osteoblastic cell culture with Ti-binding RGD 240 min 
after seeding the culture. Bar = 10μm 
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Figure 4 
The expression levels of BSP mRNA determined by Real Time PCR 
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Figure 5 
The expression levels of Alkaline phosphatase mRNA determined by Real Time PCR 
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CHAPTER 4 
DISCUSSION 
 
The success of osseointegration is determined by the integration into tissue of 
surrounding biomaterial substances. Osseointegration of dental implants is dependent on the 
attachment and spreading of osteoblast-like cells on the implant surface. One way to measure 
whether the implant surface might be favorable for this phenomenon is to incubate 
osteoblast-like cells on prepared titanium surfaces in vitro and determine initial attachment to 
these surfaces. There may be optimum surface microroughness that can affect initial cellular 
events such as attachment and spreading. 
 Osteoblast differentiation and responses during osseointegration are influenced by the 
implant surface microtopography, associated extracellular matrix proteins and their 
respective interin receptors. (Schneider and Burridge 1994; Lincks, Boyan et al. 1998; 
Okamoto, Matsuura et al. 1998; Cooper, Masuda et al. 1999; Shin, Zygourakis et al. 2004) 
 Many studies have been directed at attempts to comprehend the interaction of 
osteoblasts with various dental implants, exam cell adhesion and morphology, DNA 
synthesis, integrin and extracellular matrix expression and enzyme activity, and describe a 
variety of cellular responses to various implant surface conditions.(Bowers, Keller et al. 
1992; Schneider and Burridge 1994; Masuda, Salvi et al. 1997; Biesalski, Knaebel et al. 
2006) 
 
Bone growth is related to differentiation while it is formatting throughout the life of the 
organism through tissue remodeling. For example, osteoclastic bone resorption must 
correspond to osteoblastic activity resulting in new bone formation. The differentiation stages 
of osteoblasts are apparent during formation of bone tissue. Adherence of osteoblasts 
produce high levels of type I collagen, alkaline phosphates, and extracellular matrix 
mineralization. Moreover, mineralization influences cell shape and metabolic changes in the 
osteoblasts, which develop into the osteocytes surrounded with mineralized bone matrix. In 
general, the source of stem cells of osteoblasts is a pluripotent mesencymal fibroblast. 
 Specific genes encode proteins that support proliferation by functioning as 
transactivation factors and as proteins that play a primary role in packaging newly replicated 
DNA into chromatin, as in histones during this proliferation period, and fundamental to the 
development of bone cell phenotype, several genes associated with formation of the 
extracellular matrix are actively expressed. Theses specific genes are gradually down-
regulated during subsequent stages of osteoblast differentiation. With the decline in DNA 
synthesis, the expression of alkaline phosphates (enzyme activity and mRNA), a protein 
associated with the bone cell phenotype, increases more than 10-fold immediately after the 
down-regulation of proliferation. During this period extracellular matrix undergoes a series 
of modifications in composition and organization that renders it competent for mineralization 
stages, and cellular levels of alkaline phosphates mRNA decline.(Stein, Lian et al. 1990) 
  
 
Morphology of the titanium surfaces 
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One of major factors in the success of implants is their surface property. The layer of 
macromolecules and water influences the behavior of cells when the cell starts to adhere on 
the implant surface. In many in vivo studies, rough surfaces were found to produce better 
bone fixation than smooth surfaces.(Thomas and Cook 1985; Carlsson, Rostlund et al. 1988; 
Buser, Schenk et al. 1991) Several in vitro studies have also demonstrated that surface 
roughness affects cell response. The osteoblast cells exhibit greater initial attachment to 
rough Ti surfaces. Moreover, most recent studies of surface roughness have focused on cell 
attachment and shown better cell attachment on rough surface. The result of surface texture 
on later time frames of cell differentiation, matrix production, and calcification is as 
important as cell bond and will have a major role in implant prognosis and success. 
Bowers et al determined the morphology between a sandblasted surface and an acid 
edge surface of titanium. Sand blasted surfaces were highly irregular in morphology with 
many small (< 10 μm) depressions and indentations among flatter-appearing areas of various 
sizes. Acid etching also produced irregular surfaces whose morphology differed from that 
produced by sandblasting. The acid solution appeared to remove bulk metal from the surfaces 
with irregular shaped defects varying in size of up to approximately 20μm. In general, 
synthesis on rougher surfaces was greater than seen on smoother surfaces.(Bowers, Keller et 
al. 1992) 
Scanning electron microscopy was used to determine the morphologic characteristics 
of cells as a function of the various surfaces and time intervals used in this project. Early 
stages of our study show that hMSC demonstrated similar morphologic appearance on both 
prepared surfaces. The shape of the cells is spherical with a round cell in the center. They 
spread in all directions and adhere to titanium surfaces. In the late stage, cell morphology 
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was similar, yet there were more flatter and spread out cells on the Ti-binding RGD surface 
than on the other surface. Moreover, the round cells multiplied more on the flat spread out 
cells than they did in early stages. 
When comparing the morphology of the shape of the osteoblast on sandblasted 
surfaces and acid edge surfaces, our result shows that sandblasted surfaces have more spread 
type of cells than the acid edge surfaces. Furthermore, the speed of the spread osteoblast is 
faster on the sandblasted surface than the acid edge surface at the same time. Our results 
show that in the early stages of the sample, the sizes of the spread cell and  the round cell 
were small. In addition, the round cell did not show cell division. On the other hand, in the 
late stages of the sample, the cells exhibited more division and demonstrated more spread on 
the spread cell surfaces. When comparing Ti-binding RGD and Polystyrene binding RGD, 
the Ti -binding RGD show greater growth speed than the other. 
Many studies proved that the peptides attempt to develop more osteogenic inducing 
surface in order to improve oseeous differentiation the metallic surfaces by 
themselves.(Ferris, Moodie et al. 1999; Rezania and Healy 1999)  
Zreiqat et al examined the effects of chemically modifying Ti-6AI-4V surfaces with 
common RGD sequence, on the modulation of bone remodeling. Their results showed that 
human bone derived cells (HBDC) grown for 7 days on RGD surfaces displayed significantly 
increased levels of osteocalcin, and pro-collagen IαImRNAs, compared with the production 
by HBDC grown on the native Ti-6AI-4V.(Zreiqat, Akin et al. 2003) 
Rammelt et al. examined between the collagen RGD peptide and chondroitin sulfate. 
They found that an increased expression of osteogenic factors (osteocalcin, procollagen 
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mRNA) after 7days and an increased concentration of osteoblast differentiating factors. (IL-
6, osteoprotegerin) (Rammelt, Illert et al. 2006) 
Ferris et al evaluated the quality and quantity of the new bone formed in response to 
titanium rods surface-coated with the peptide sequence Arg-Gly-Asp-Cys (RGDC) using 
gold-thiol chemistry and implanted in rat femurs. Their study suggested that an RGDC 
peptide coating enhance titanium rod oseeointegration in the rat femur.(Ferris, Moodie et al. 
1999) 
Germanier et al presented to examine early bone apposition to a modified sandblasted 
and acid-etched (SLA) surface coated withan Arg-Gly-Asp (RGD)- peptide modified 
polymer (PLL-GPEG/PEG-RGD) in the maxillae of miniature pigs. Then they concluded that 
the (PLL-G-PEG/PEG-RGD) coating may promote enhaced bone apposition during the early 
stages of regeneration.(Germanier, Tosatti et al. 2006) 
Furthermore, Elmengaard et al shows encouraging results as cyclic RGD coating on 
unloaded press-fit titanium implants significantly increased bone formation on and around 
the implant.(Elmengaard, Bechtold et al. 2005) 
Current study provides evidence that the highest adherence of cell attachment is 
obtained on the rough, irregular surfaces created by sand blasting with Ti-binding RGD. At 
240 minutes, the cells had flattened on the surface and had intimated or integrated on the 
cells on the surface. If implant substrates can alter the cellular morphology following initial 
attachment, then it is imaginable that implant topography may affect 
osseointegration.(Stanford and Keller 1991) In addition, the results from SEM show that 
surface roughness of the implant with Ti-binding RGD peptide affects the biological 
responses of osseointegration. 
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Real-time PCR results demonstrated that upregulation is the key to osteoblast specific 
gene expression, such as ALP and BSP. Both enzymes initiate phosphate precipitation as an 
early indicator of osteoblastic differentiation. The ALP enzyme is often used as a marker for 
increased osteoblastic metabolic activity and an early indicator of osteoblastic differentiation. 
(Aubin 1996) 
 
 
The Arg-Gly-Asp (RGD) peptide 
 
The Arg-Gly-Asp (RGD) represents a strategy to control biological interactions at the 
cell-material interface. The tri-peptide sequence arginine-glycine-aspartic acid (RGD) is 
found in the proteins of the extracellular matrix (ECM), with various transmembrane 
receptors.(Humphries 1990)These peptides are known to improve the tissue-material contact 
owing to highly specific binding to cellular membrane receptors known as integrants, thereby 
promoting the adhesion and migration to borosilicate glass and titanium surface using 
silanisation chemistry. A tryptophan residue was incorporated into the amino acid sequences 
of selected peptides to facilitate the detection of the covalently bound peptides. (Senyah, 
2005) 
The RGD sequence is found in many extracellular matrix proteins, such as 
fibronectin, osteopontin, bone sialoprotein and collagen type I. The immobilization of 
synthetic RGD- peptides is an attempt to control the cell response at the material tissue 
interface. The extent to which the peptides attract cells and allow settlement differs largely 
depending on their amino acid composition and length of the overall peptide sequence. Our 
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study shows that the Ti-binding RGD stimulate more cell adhesion than Polystyrene banding 
RGD.  
Stein et al mentioned that a reciprocal and functionally coupled relationship between 
the decline in proliferate activity and the subsequent induction of genes associated with 
matrix maturation and mineralization is supported by a temporal sequence of events in which 
an enhanced expression of alkaline phosphates occurs immediately after the proliferate 
period, and later an increased expression of osteocalcin and osteopontin at the onset of 
mineralization. In addition, mineralization induces cell shape and metabolic changes in the 
osteoblast, which develops into the osteocyte surrounded by mineralized bone matrix or 
flattened bone lining cell apposed to the mineralized surface.(Stein, Lian et al. 1990) 
 
 
Bone sialoprotein (BSP) 
 
Bone sialoprotein (BSP) is an acidic phosphoprotein isolated from bone matrix 
containing very high concentration of O-glycosidically linked sialic acid residues. It appears 
to be present only within bone tissue upon Northern blot analysis. BSP has a peptide 
backbone of 33,600 Da and total weight of approximately 59,000Da. As with osteopontin, 
this molecule contains a significant concentration of acid amino acids (32% are Glutamate), 
including a ten amino acidic repeated sequence of glutamic acid that is thought to convey 
mineral binding properties to the molecule. Upon sequencing, a RGD sequence was detected 
that appears to convey specificity for the vitronectin integrant receptor. Therefore, much like 
osteopontin (BSP-I), bone sialoprotein has cell attachment properties, although apparently 
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with less affinity. (Stanford 1991). BSP is transiently expressed very early and then 
unregulated again in differentiated osteoblasts forming bone. (Davis 2000) Moreover, the 
addition of dexamethasone or other factors as BMPs increases the number of bone nodules or 
bone colonies in calvarias-derived and bone-marrow stromal-cell cultures, suggesting the 
presence of “inducible” osteoprogenitor cell populations as well. Real Time PDR showed 
significant increases in BSP expression in cells grown on roughened with RGD peptide, as 
compared without RGD peptide. The response is to increase production of a factor that 
promotes early stages of bone formation. 
 
 
Alkaline phosphates (ALP) 
 
The expression of alkaline phosphates mRNA and enzyme activity before the 
initiation of osteoblast mineralization suggests that alkaline phosphates may be involved 
preparing the extracellular matrix for the ordered deposition of mineral.(Stein, Lian et al. 
1990) The induction of these mineralization-associated genes may reflect an acquisition of 
osteoblast properties necessary for signaling bone turnover in vivo. The patterns of 
expression of the ALP and the synthesis of the endcoded proteins, and determined 
biochemically and by histochemical staining, demonstrate that a temporal sequence of gene 
expression exists during the culture period associated with development of the extracellular 
matrix and reflects maturation of the osteoblast phenotype in vitro.(Lian and Gundberg 1988) 
By combined thymidine labeling and in situ autoradiography with alkaline phosphates 
histochemistry, it has been possible to establish a direct relationship between proliferation 
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and initiation of tissue-specific gene expression at the single-cell level during the osteoblast 
developmental sequence. The down-regulation of proliferation induces the expression of 
some genes that are normally expressed later in the osteoblast developmental sequence is 
derived from experiments that establish that inhibition of DNA synthesis in activity 
proliferation of cell growth genes.(Owen, Aronow et al. 1990) 
This is equivalent with a fourfold increase in alkaline phosphates mRNA levels, and it 
indicates that the premature down regulation of proliferation induces the expression of an 
early marker for the extracellular matrix maturation period of the osteoblast development 
sequence.(Majeska, Nair et al. 1985) 
The recent studies showed that the actual role of the ALP stimulates the mineralization 
of the bone. ALP is an early marker of osteogenic differentiation. While this enzyme activity 
is present in all cell membranes, it is found in higher levels in cells which mineralize their 
matrix such as osteoblasts. As osteoblasts mature, they produce extracellular matrix vesicles 
which are enriched in alkaline phosphates specific activity; because of this specific 
enrichment, an alkaline phosphate is the marker enzyme for this extracellular organelle. 
Matrix vesicles are associated with the onset of calcification and they contain enzymes 
necessary for matrix modification necessary for crystal deposition and growth. The results of 
this study show clearly the effects of RGD modified peptide.  
Wang et al revealed that a higher level of ALP activity at the cranial site may promote 
the initiation of mineral deposition in the presence of BSP. Our result shows that the ALP 
expression had increased at day 7. However, the BSP expression started increasing at day 14. 
That is consistent with that ALP in matrix mineralization starts earlier than BSP 
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expression.(Wang, Zhou et al. 2006) In general, the induction of mineralization-associated 
genes may reflect an acquisition of osteoblast properties. 
Stein et al used rat osteoblast development sequence to explain that gene expression had 
three distinct periods; proliferation, extracellular matrix maturation, and mineralization; and 
those patterns suggest two important transition points on osteoblast development sequence 
which are important regulatory signs. (They might be very important for the progressive 
expression of the bone cell phenotype to proceed. In the beginning, proliferation decreases 
and gene expression connects the extra cellular matrix and maturation is initiated. Then, 
mineralization starts increasing. In addition, the study confirms the day 20 restriction point 
for mineralization by showing that mineralization occurs prior to osteoblast growth. The 
specific genes encode proteins that support proliferation by functioning as transactivation 
factors and as proteins that play the primary role in packaging newly replicated DNA into 
chromatin, as in histones during this proliferation period, and fundamental to the 
development of bone cell phenotype, several genes associated with formation of the 
extracellular matrix are actively expressed. These specific genes are gradually down-
regulated during subsequent stages of osteoblast differentiation. With the decline in DNA 
synthesis, the expression of alkaline phosphates (enzyme activity and mRNA), a protein 
associated with the bone cell phenotype, increases more than 10-fold immediately after the 
down-regulation of proliferation. During this period the extracellular matrix undergoes a 
series of modifications in composition and organization that renders it competent for 
mineralization stages, and cellular levels of alkaline phosphates mRNA decline.(Stein, Lian 
et al. 1990; Boyan, Lossdorfer et al. 2003)  In this study, ALP expression was significantly 
higher with RGD peptide than without peptide at days 7 and 14, and the achievement of the 
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maximum ALP activity was day 7. Both with RGD peptide and without peptide showed very 
low ALP activity at day 1 and day 3.However, at days 7 and 14 the ALP activity increased 
dramatically. This result support that ALP is usually up regulated at the earlier stages of 
osteoblast differentiation.(Bancroft, Sikavitsas et al. 2002) 
 
  The current study shows that different implant surfaces and RGD modified surface 
microtopographies can influence the consequences in expression of the key to osteogenic 
genes as ALP and BSP. This suggests that the interaction of the osteoblasts with the 
extracellular matrix components on the different modified implant surface can effect gene 
expression. Moreover, the AFF 6008 peptide were capable of mediating specific interaction 
with hMSC derived osteoblasts.  
 Consequently to the significant effect of the peptide on the differentiation and 
mineralization of hMSC, the level of expression of the ALP and BSP was significantly 
affected by the AFF 6008 peptide. 
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CHAPTER 5 
CONCLUSION 
 
This investigation is to use peptide affinity for different surfaces implants and permit the 
direct adhesion of peptides containing RGD to promote cell adhesion. Consequently to the 
significant effect of the peptide on the differentiation and mineralization of hMSC, the level 
of expression of the ALP and BSP was significantly affected by the AFF 6008 peptide in the 
early stage of osseointegration. 
The results, furthermore, suggest that additional RGD coating may be effective in early 
formation of bone implant contacts. 
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